With 1.89 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.87 million shares. The 52-week range on CHRS shows that it touched its highest point at $2.78 and its lowest point at $0.66 during that stretch. It currently has a 1-year price target of $7.00. Beta for the stock currently stands at 0.92.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CHRS was down-trending over the past week, with a drop of -0.90%, but this was down by -20.86% over a month. Three-month performance surged to 42.38% while six-month performance fell -12.70%. The stock lost -61.40% in the past year, while it has lost -20.29% so far this year. A look at the trailing 12-month EPS for CHRS yields -0.10 with Next year EPS estimates of -0.43. For the next quarter, that number is -0.31. This implies an EPS growth rate of 113.96% for this year and -222.35% for next year. EPS is expected to grow by 33.84% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.73%.
Float and Shares Shorts:
At present, 115.21 million CHRS shares are outstanding with a float of 111.26 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CHRS since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.35823 being high and $0.34813 being low. For CHRS, this leads to a yearly average estimate of $0.35318. Based on analyst estimates, the high estimate for the next quarter is -$0.04 and the low estimate is -$0.08. The average estimate for the next quarter is thus -$0.06.
